Literature DB >> 14512622

Nanoparticle-based bio-bar codes for the ultrasensitive detection of proteins.

Jwa-Min Nam1, C Shad Thaxton, Chad A Mirkin.   

Abstract

An ultrasensitive method for detecting protein analytes has been developed. The system relies on magnetic microparticle probes with antibodies that specifically bind a target of interest [prostate-specific antigen (PSA) in this case] and nanoparticle probes that are encoded with DNA that is unique to the protein target of interest and antibodies that can sandwich the target captured by the microparticle probes. Magnetic separation of the complexed probes and target followed by dehybridization of the oligonucleotides on the nanoparticle probe surface allows the determination of the presence of the target protein by identifying the oligonucleotide sequence released from the nanoparticle probe. Because the nanoparticle probe carries with it a large number of oligonucleotides per protein binding event, there is substantial amplification and PSA can be detected at 30 attomolar concentration. Alternatively, a polymerase chain reaction on the oligonucleotide bar codes can boost the sensitivity to 3 attomolar. Comparable clinically accepted conventional assays for detecting the same target have sensitivity limits of approximately 3 picomdar, six orders of magnitude less sensitive than what is observed with this method.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14512622     DOI: 10.1126/science.1088755

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  335 in total

Review 1.  Inorganic Complexes and Metal-Based Nanomaterials for Infectious Disease Diagnostics.

Authors:  Christine F Markwalter; Andrew G Kantor; Carson P Moore; Kelly A Richardson; David W Wright
Journal:  Chem Rev       Date:  2018-12-04       Impact factor: 60.622

2.  Duplex end breathing determines serum stability and intracellular potency of siRNA-Au NPs.

Authors:  Pinal C Patel; Liangliang Hao; Weng Si Au Yeung; Chad A Mirkin
Journal:  Mol Pharm       Date:  2011-06-28       Impact factor: 4.939

3.  Microfluidic electrochemical immunoarray for ultrasensitive detection of two cancer biomarker proteins in serum.

Authors:  Bhaskara V Chikkaveeraiah; Vigneshwaran Mani; Vyomesh Patel; J Silvio Gutkind; James F Rusling
Journal:  Biosens Bioelectron       Date:  2011-05-11       Impact factor: 10.618

Review 4.  Gold nanoparticles: preparation, properties, and applications in bionanotechnology.

Authors:  Yi-Cheun Yeh; Brian Creran; Vincent M Rotello
Journal:  Nanoscale       Date:  2011-11-10       Impact factor: 7.790

5.  Multidentate-protected colloidal gold nanocrystals: pH control of cooperative precipitation and surface layer shedding.

Authors:  Brad A Kairdolf; Shuming Nie
Journal:  J Am Chem Soc       Date:  2011-04-27       Impact factor: 15.419

6.  PEG branched polymer for functionalization of nanomaterials with ultralong blood circulation.

Authors:  Giuseppe Prencipe; Scott M Tabakman; Kevin Welsher; Zhuang Liu; Andrew P Goodwin; Li Zhang; Joy Henry; Hongjie Dai
Journal:  J Am Chem Soc       Date:  2009-04-08       Impact factor: 15.419

7.  Gene regulation with polyvalent siRNA-nanoparticle conjugates.

Authors:  David A Giljohann; Dwight S Seferos; Andrew E Prigodich; Pinal C Patel; Chad A Mirkin
Journal:  J Am Chem Soc       Date:  2009-02-18       Impact factor: 15.419

Review 8.  Silver nanoparticle-oligonucleotide conjugates based on DNA with triple cyclic disulfide moieties.

Authors:  Jae-Seung Lee; Abigail K R Lytton-Jean; Sarah J Hurst; Chad A Mirkin
Journal:  Nano Lett       Date:  2007-06-16       Impact factor: 11.189

9.  Curvature-induced base pair "slipping" effects in DNA-nanoparticle hybridization.

Authors:  Haley D Hill; Sarah J Hurst; Chad A Mirkin
Journal:  Nano Lett       Date:  2009-01       Impact factor: 11.189

Review 10.  Advances and challenges in biosensor-based diagnosis of infectious diseases.

Authors:  Mandy L Y Sin; Kathleen E Mach; Pak Kin Wong; Joseph C Liao
Journal:  Expert Rev Mol Diagn       Date:  2014-02-13       Impact factor: 5.225

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.